Slov Vet Res 2023 | Vol 60 No 4 | 213 Aggressive Behavior in a Bitch After Deslorelin Implant Insertion Key words bitch; aggression; behavior; deslorelin implant; long-lasting GnRH Maja Zakošek Pipan1*, Darja Pavlin2 1Clinic for Reproduction and Large Animals, 2Small Animal Clinic, Veterinary Faculty, University of Ljubljana, Gerbičeva 60, 1000 Ljubljana, Slovenia Both authors contributed equally to this work and share first and last authorship *Corresponding author: maja.zakosekpipan@vf.uni-lj.si Abstract: In male dogs, long-acting gonadotropin-releasing hormone (GnRH) analogs are widely accepted as an alternative to surgical castration but are also used to sup- press and induce estrus in bitches (off label). Behavioral changes reported in bitches in association with the use of long-acting GnRH analogs have included male-like behav- ior associated with triggered estrus, increased food intake, enlargement of mammary glands and milk production, pseudopregnancy, and urinary incontinence. In male dogs, intra-species and rarely inter-species aggression may occur during the flare-up effect. However, at the time of downregulation, this behavior should no longer occur if it is tes- tosterone dependent. An intact, three-year-old female cocker spaniel with Addison’s disease was admitted to our clinic for consultation on spaying options because of pseudopregnancies followed by mastitis, which had to be treated with antibiotics, after her heat cycles. The owners were hesitant about surgical sterilization and therefore, deslorelin implant was inserted. Approximately one month after implantation, owners observed the onset of aggressive behavior, including incessant barking, extreme irritability, and aggression toward other dogs and towards family members. The behavior problems started to escalate and the owners were not able to handle her anymore. After removal of the implant, the observed aggression ceased, and the bitch returned to normal behavior. Although aggressive behavior toward other dogs and sometimes even toward owners has been observed after neutering or insertion of a deslorelin implant, this is the first report of extremely aggressive behavior toward owners and other dogs in a female dog after insertion of a 4.7 mg deslorelin implant. Received: 24 May 2023 Accepted: 25 August 2023 DOI 10.26873/SVR-1781-2023 UDC 636.7:612.621.5:577.175.6:591.5 Pages: 213–18 Case Report Introduction Aggression is the most common and serious behavioral problem in dogs. It is also the most common reason pet owners seek professional help from veterinarians and be- haviorists (1). Aggression in dogs can be directed toward familiar people, toward strangers, or toward other dogs. Aggressive behavior in dogs is a common problem in soci- ety and a frequent cause of dog-human bites (2), surrender of adult dogs to shelters, and euthanasia of adult dogs (3). Gonadectomy is commonly used to treat and prevent be- havior problems, including aggressive behavior in dogs and it is advocated by veterinarians as a way to make dogs better-behaved companions (4). However, research- ers provide conflicting information. In a study by Hopkins et al. (5), it was found that in gonadectomized dogs, ag- gressiveness toward other dogs decreased by 62%, but territorial and fear-induced aggressive behavior remained 214 | Slov Vet Res 2023 | Vol 60 No 4 unchanged. The same observations were made in another study in which neutering had an effect on all behavioral problems related to aggression except aggressive behavior toward strangers (6). In contrast, other studies suggest no discernible pattern of changes in aggression (7, 8). Some studies note that gonadectomized dogs of both sexes are significantly more likely than intact dogs to bark, growl, lunge, snap, open their eyes wide, and raise or curl their lips when approached by an unknown human or dog (9, 10). A recent study of 15, 370 dogs concluded that no single fac- tor is responsible for aggressive behavior in dogs, but that there are multiple environmental and genetic factors that contribute to aggressive behavior. Neutering does not re- sult in a predictable decrease in aggressive behavior in all male and female dogs, although it may be effective in some (4). This supports the previous 2013 recommendation from the Society for Theriogenology and the American College of Theriogenology Board of Directors that gonadectomy should be decided on a case-by-case basis (11). Gonadotropin-releasing hormone (GnRH) is a key regulator of reproductive function. It is released in a pulsatile fashion from hypothalamic neurons. The peptide binds to specific GnRH receptors on pituitary gonadotrophs. Its activation leads to synthesis and secretion of LH and FSH. In females, gonadotropin secretion from the pituitary gland is modulat- ed by estradiol and progesterone. These feedback effects of ovarian steroids initiate the LH surge and lead to sup- pression of GnRH release in the luteal phase. The pulsatile release of GnRH from the hypothalamus is essential for the maintenance of ovarian function (12). Slow-release GnRH agonist implants are widely accepted as an alternative to surgical castration in male dogs and cats. Although deslo- relin implants are approved in the EU for male dogs and, as of June 2022, for male cats and prepubertal bitches (13), numerous studies have been conducted in the adult bitch to investigate its use as a contraceptive and/or method of estrus induction (14, 15, 16). The first step in the mecha- nism of action is a flare-up effect with an increase in go- nadotropin synthesis. Such increased gonadotropin syn- thesis leads to estrus induction in females, when treated in anestrus (14, 15). This was indeed observed when females in anestrus were treated with GnRH analog (14). However, when females in diestrus with P4 > 5 ng/ml were treated, the first report concluded that there is no flare-up effect (17). Later studies showed that the initial flare up effect is associated with estrus induction when deslorelin is ad- ministered to bitches both in anestrus as well as (although more rarely) in diestrus (18). Most authors have confirmed that all adult bitches respond in the same manner regard- less of size and age; however, depending on the stage of the cycle, the bitch’s response may vary (19, 20, 21). After the flare-up effect desensitization of the GnRH receptors occurs, resulting in a transient, long-term, and fully revers- ible down-regulation of reproductive endocrine functions in dogs (21, 22, 23). These promising results led to the use of the implants for estrus induction and suppression in bitch- es predisposed to the side effects of sterilization (off-label use). Although many adult bitches do well when treated with deslorelin, some signs such as persistent oestrus, pyometra, urinary incontinence, ovarian tumors, and minor behavioral and physical changes may occur (24). Case An intact, three-year-old female cocker spaniel was admit- ted to our hospital for consultation on spaying options. The dog was diagnosed with Addison’s disease at one year of age and was well controlled with a combination of oral hy- drocortisone (Hydrocortisone Roussel, Sanofi Winthorp Industrie, France) at a dosage of 0.4 mg/kg/12h and subcu- taneous desoxycorticosterone pivalate (Zycortal, Dechra, UK) at a dosage of 1.3 mg/kg/30 days. Based on clinical response to therapy and biannual laboratory checks, her disease was stable. Her first heat occurred at 9 months of age, and since then she has had regular cycles every 6 months. After the fourth cycle, she developed pseudopreg- nancy followed by mastitis, which had to be treated with antibiotics. The owners wanted to stop the cycles and pre- vent the pseudopregnancy but were hesitant about surgical sterilization because of the risk of anesthesia, due to her condition. Moreover, they feared irreversible consequences of gonadectomy, especially weight gain. They decided to use a deslorelin implant because its effect is reversible and can be implanted without surgical intervention. Deslorelin (Suprelorin 4.7 mg implant for dogs, Virbac, France) was implanted subcutaneously in the umbilical region on day 23 after the onset of visible signs of proes- trus. Diestrus was confirmed by vaginal cytology, but pro- gesterone was not measured. Approximately one month after implantation, owners observed the onset of aggres- sive behavior, including incessant barking, extreme irritabil- ity, and aggression toward other dogs. Such behavior was not normal for this previously very well-mannered dog. The aggression escalated rapidly with her becoming aggres- sive also toward people, firstly toward strangers but later toward family members as well, culminating in a bite attack requiring medical intervention on one of the owners. The change in behavior was so extreme that the owners were unable to physically interact with her any more as she at- tacked anyone who approached her. About 70 days after implantation signs of pseudopregnancy became visible with enlarged mammary glands but no milk production and lethargy. Another side effect of the implant was polyphagia and about 10% weight gain. Approximately two and a half months after administration, the implant was removed. All signs of aggressive behavior ceased within the next few months, and according to the owners, she returned to the gentle dog she was prior to im- plantation. Within two weeks, she also lost 600 g in weight despite being fed the same diet. In the two years after the implant removal, once resolved, the aggressive behav- ior never reoccurred although her heat cycles returned to Slov Vet Res 2023 | Vol 60 No 4 | 215 normal as before deslorelin implantation. The exact course of events are shown in Figure 1. Discussion The present case is the first report of the occurrence of severe aggression in a bitch after the insertion of a des- lorelin implant. Surgical sterilization is often suggested to the owners to alleviate unwanted and aggressive behavior in some dogs (25). Because of their ability to suppress sex steroid hormones, GnRH agonist-releasing implants may also be useful in modifying or minimizing testosterone-re- lated behaviors. In castrated male dogs and dogs with des- lorelin implants, improvements have been noted in sexually dimorphic male behaviors described as libido, hypersexu- ality, intermale conflict, and excessive urine marking (26). Therefore, it has been suggested that implants releasing GnRH agonists are an alternative for clients seeking to alter testosterone-mediated behavior in their male dogs without having to perform castration or as a trial to what could be achieved by permanent sterilization (27). On the other hand, recent studies have shown that the likelihood of undesir- able behavior increases significantly in neutered animals. Neutered dogs were more aggressive, more fearful, more restless, more difficult to train, and less responsive to sig- nals (2, 4, 23). In addition, and of bigger importance, there is a risk of an increase in dominance aggression toward fam- ily members (28), with owners (2) and children (29) being bitten more likely by neutered animals. Another study found that these effects were more pronounced when animals were neutered before puberty (27). The behavioral aspect of GnRH agonist implants in bitch- es has not yet been described, but it is generally expected that the effects should be similar to those of sterilization. However, there is a major difference between surgical and medical castration, namely that gonadotropin levels are very high after surgical castration (30) whereas they are likely to be low to basal during deslorelin treatment be- cause of the inhibitory effect of deslorelin on gonadotropin release. In general, it is not known whether such a change may have an impact on disease and possibly on behavior. In the present case, severe aggressive behavior toward oth- er dogs and strangers was initially observed. Subsequently, the aggression toward family members escalated and the dog became so aggressive that the owners could no longer safely handle her. Most studies have found that the risk of unwanted aggressive behavior after sterilization is higher in dogs that already showed behavioral problems before go- nad removal (31). However, in our case, no aggression was observed in this bitch before implant placement, and the aggression resolved after implant removal. We must mention that the dog suffered from Addison’s disease and was treated with a physiological dose of corti- costeroids and mineralocorticoids. Exogenous corticoste- roids are synthetic analogues of natural steroid hormones and are used in both human and veterinary medicine mainly for their anti-inflammatory and immunosuppressive ef- fects. The synthetic analogues of cortisol have increased glucocorticoid activity (32). Exogenous corticosteroid treatments have been reported to cause negative emotion- al states in human patients and laboratory animals, with similar changes noted in domestic dogs (33). Behavioral changes associated with exogenous corticosteroid treat- ments in dogs have been reported in only a few studies (33, 34), showing increased anxious behavior and avoidance of contact with humans. This may include a greater tendency to retreat when approached or attempts to snap or bite un- der these circumstances. It has been reported by owners that dogs treated with corticosteroids tended to react ag- gressively when petted or even approached, and that their dogs also appeared to be significantly more prone to avoid people or situations (34, 35, 36). It was also found that dogs receiving corticosteroids after being referred for behavioral Figure 1: The exact course of events that took place from the insertion of the implant to its removal 216 | Slov Vet Res 2023 | Vol 60 No 4 problems were significantly more likely to exhibit negative behavior compared to dogs not treated with these medi- cations (33). Thus, aggressive behavior in this bitch could potentially be caused by treatment with corticosteroids. However, it should be mentioned that the bitch had been taking these medication for more than two years before im- plantation of deslorelin and returned to her normal behavior after the implant was removed despite continued treatment with the same dose and type of corticosteroids. In humans, it has recently been found that Addison’s dis- ease can cause psychiatric symptoms that often accom- pany the cardinal symptoms of adrenal insufficiency and are related to the severity of the disease (37). Therefore, un- treated and uncontrolled Addison’s disease in dogs could cause similar problems and lead to aggressive behavior. However, as mentioned earlier, the bitch had been treated with medication for more than two years and was very well controlled. Because both corticosteroids and gonadecto- my produce behavioral changes in some animals, it is pos- sible that the corticosteroid treatment with the implant in- creased the behavioral changes. Despite physiologic doses of corticosteroids used in this case such scenario can not be fully excluded. A possible mechanism to investigate may be that deslore- lin treatment somehow stimulated minor adrenal function by stimulating ACTH-secreting neurons of the pituitary gland, thereby increasing adrenal cortisol production and causing a hyperadrenocortical state (due to concomitant exogenous corticosteroid administration). A recent article (13) reported the development of pituitary carcinoma caus- ing a Cushing-like syndrome in a bitch chronically treated with deslorelin for urinary incontinence. A relationship be- tween the pituitary tumor and the clinical signs could not be confirmed, but the possibility that deslorelin causes a minor stimulation of the pituitary corticotrophs should not be discounted. From this point of view, it would have been interesting to know the status of Na-K balance in this bitch during the period of increased aggressiveness, but we do not have these data. This case also raises the question of the risk of taking mul- tiple endocrine drugs at the same time and their possible interactions on general health and behavior. Since inappro- priate behavior is the most common cause of animals end- ing up in shelters or abandoned by their owners, it is very important to inform owners before sterilization about pos- sible behavioral side effects which, although rare, are irre- versible following surgical gonadectomy. The use of GnRH agonist implants to determine the effects of gonad removal is therefore beneficial and strongly recommended for male dogs and cats, perhaps even prepubertal females, but we cannot say with certainty at this time that such treatment is also recommended for adult females, given all the report- ed side effects. The veterinary profession should increase awareness about treatments that alter animal behavior and the importance of monitoring and reporting behavioral side effects as adverse events. Drug-drug interactions should be discussed more frequently, as they can affect the ef- fectiveness of the medication and treatment, cause unex- pected side effects, or enhance the effects of a particular medication. Acknowledgements Authors would like to thank owners for their cooperation. Conflict of Interest: The authors declare that the research was conducted in the absence of any commercial or finan- cial relationships that could be construed as a potential conflict of interest. Author Contributions: Both authors contributed equally to this paper. Funding: The authors acknowledge the financial support from the Slovenian Research Agency (research core fund- ing No. P4-0053). References 1. Moxon R, Whiteside H, England GCW. Incidence and impact of dog at- tacks on guide dogs in the UK: an update. Vet Rec 2016; 178(15): 367. doi:10.1136/vr.103433 2. Matthias J, Templin M, Jordan MM, Stanek D. Cause, setting and own- ership analysis of dog bites in bay county, Florida from 2009 to 2010. Zoonoses Public Health 2015; 62(1): 38–43. doi: 10.1111/zph.12115 3. Hemy M, Rand J, Morton J, Paterson M. Characteristics and outcomes of dogs admitted into Queensland RSPCA Shelters. Animals (Basel) 2017; 7(12): 67. doi: 10.3390/ani7090067 4. Farhoody P, Mallawaarachchi I, Tarwater PM, Serpell JA, Duffy DL, Zink C. Aggression toward familiar people, strangers, and conspecif- ics in gonadectomized and intact dogs. Front Vet Sci 2018; 5: 18. doi: 10.3389/fvets.2018.00018 5. Hopkins SG, Schubert TA, Hart BL. Castration of adult male dogs: ef- fects on roaming, aggression, urine marking, and mounting. J Am Vet Med Assoc 1976; 168(12): 1108–10. 6. Neilson JC, Eckstein RA, Hart BL. Effects of castration on problem be- haviors in male dogs with reference to age and duration of behavior. J Am Vet Med Assoc 1997; 211(2): 180–2. 7. Podberscek AL, Serpell JA. Environmental influences on the expres- sion of aggressive behaviour in English Cocker Spaniels. Appl Anim Behav Sci 1997; 52(3/4): 215–27. 8. Maarschalkerweerd RJ, Endenburg N, Kirpensteijn J, Knol BW. Influence of orchiectomy on canine behaviour. Vet Rec 1997; 140(24): 617–9. 9. Kim HH, Yeon SC, Houpt KA, Lee HC, Chang HH, Lee HJ. Effects of ovariohysterectomy on reactivity in German Shepherd dogs. Vet J 2006; 172(1): 154–9. 10. Garde E, Pérez GE, Vanderstichel R, Dalla Villa PF, Serpell JA. Effects of surgical and chemical sterilization on the behavior of free-roaming male dogs in Puerto Natales, Chile. Prev Vet Med 2016; 123: 106–20. Slov Vet Res 2023 | Vol 60 No 4 | 217 11. Society for Theriogenology. Basis for position on mandatory spay- neuter in the canine and feline. Providence: Society for theriogenology, 2023. https://cdn.ymaws.com/www.theriogenology.org/resource/ resmgr/docs/spay-neuter_basis.pdf (5. 12. 2023) 12. de Gier J, Beijerink N, Kooistra H, Okkens A. Physiology of the canine anoestrus and methods for manipulation of its length. Reprod Domest Anim 2008; 43(suppl. 2): 157–64. 13. Romagnoli S, Diana A, Ferré-Dolcet L, Fontaine C, Milani C. Chronic use of deslorelin in dogs: six cases (2005-2022). Animals (Basel) 2023;13(2): 265. doi: 10.3390/ani13020265 14. Romagnoli S, Stelletta C, Milani C, Gelli D, Falomo ME, Mollo A. Clinical use of deslorelin for the control of reproduction in the bitch. Reprod Domest Anim 2009; 44(suppl. 2): 36–9. doi: 10.1111/j.1439-0531.2009.01441.x 15. Fontaine E, Mir F, Vannier F, et al. Induction of fertile oestrus in the bitch using Deslorelin, a GnRH agonist. Theriogenology 2011; 76(8): 1561–6. doi: 10.1016/j.theriogenology.2011.06.031 16. von Heimendahl A, Miller C. Clinical evaluation of deslorelin to induce oestrus, ovulation and pregnancy in the bitch. Reprod Domest Anim 2012; 47(6): 398-9. doi: 10.1111/rda.12080 17. Trigg TE, Doyle AG, Walsh JD, Swangchan-uthai T. A review of ad- vances in the use of the GnRH agonist deslorelin in control of re- production. Theriogenology 2006; 66(6/7): 1507–12. doi: 10.1016/j. theriogenology.2006.02.037 18. Fontaine E, Fontbonne A. Use of deslorelin to control fertility in the bitch. In: Symposium deslorelin: deslorelin in practice. 7th EVSSAR Biennial Congress Louvain la Neuve, 2010. 19. Palm J, Reichler IM. Der Einsatz von Deslorelinazetat (Suprelorin®) in der Kleintiermedizin. Schweiz Arch Tierheilkd 2012; 154(1): 7–12. doi:10.1024/0036-7281/a000286 20. Maenhoudt C, Santos N, Fontbonne A. Suppression of fertility in adult dogs. Reprod Domest Anim 2014; 49(suppl. 2): 58–63. doi: 10.1111/ rda.12306 21. Fontaine E, Fontbonne A. Clinical use of GnRH agonists in canine and feline species: GnRH agonists in canine and feline reproduc- tion: a review. Reprod Domest Anim 2011; 46(2): 344–53. doi: 10.1111/j.1439-0531.2010.01705.x 22. Walter B, Otzdorff C, Brugger N, Braun J. Estrus induction in Beagle bitches with the GnRH-agonist implant containing 4.7 mg Deslorelin. Theriogenology 2011; 75(6): 1125–9. doi: 10.1016/j. theriogenology.2010.11.022 23. Maenhoudt C, Santos N, Fontaine E, et al. Results of GnRH agonist im- plants in oestrous induction and oestrous suppression in bitches and queens. Reprod Domest Anim 2012; 47(suppl. 6): 393–7. doi: 10.1111/ rda.12041 24. Brändli SP, Palm J, Kowalewski MP, Reichler IM. Long-term ef- fect of repeated deslorelin acetate treatment in bitches for repro- duction control. Theriogenology, 2021; 173: 73–82. doi: 10.1016/j. theriogenology.2021.07.015 25. Hart BL, Eckstein RA. The role of gonadal hormones in the occurrence of objectionable behaviours in dogs and cats. Appl Anim Behav Sci 1997; 52(3/4): 331–44. 26. Goericke-Pesch S. Long-term effects of GnRH agonists on fertility and behaviour. Reprod Domest Anim 2017; 52(suppl. 2): 336–47. 27. Driancourt MA, Briggs JR. Gonadotropin-Releasing Hormone (GnRH) agonist implants for male dog fertility suppression: a review of mode of action, efficacy, safety, and uses. Front Vet Sci 2020; 7: 483. doi: 10.3389/fvets.2020.00483 28. O’Farrell V, Peachey E. Behavioural effects of ovariohysterectomy on bitches. J Small Anim Pract 1990; 31(12): 595–8. 29. Reisner IR, Shofer FS, Nance ML. Behavioral assessment of child-di- rected canine aggression. Inj Prev 2007; 13(5): 348–51. doi: 10.1136/ ip.2007.015396 30. Asher L, England GCW, Sommerville R, Harvey ND. Teenage dogs? Evidence for adolescent-phase conflict behaviour and an association between attachment to humans and pubertal timing in the domestic dog. Biol Lett 2020; 16(5): 20200097. doi:10.1098/rsbl.2020.0097 31. Palestrini C, Mazzola SM, Caione B, et al. Influence of gonadectomy on canine behavior. Animals (Basel) 2021; 11(2): 553. doi:10.3390/ ani11020553 32. Samuel S, Nguyen T, Choi HA. Pharmacologic characteristics of cor- ticosteroids. J Neurocritical Care 2017; 10(2): 53–9. doi:10.18700/ jnc.170035 33. Notari L, Kirton R, Mills DS. Psycho-behavioural changes in dogs treated with corticosteroids: a clinical behaviour perspective. Animals (Basel) 2022; 12(5): 592. doi: 10.3390/ani12050592 34. Notari L, Mills D. Possible behavioral effects of exogenous corticoste- roids on dog behavior: a preliminary investigation. J Vet Behav 2011; 6(6): 321–7. doi:10.1016/j.jveb.2011.02.004 35. Elkholly DA, Brodbelt DC, Church DB, et al. Side effects to systemic glucocorticoid therapy in dogs under primary veterinary care in the UK. Front Vet Sci 2020; 7: 515. doi: 10.3389/fvets.2020.00515 36. Notari L, Burman O, Mills D. Behavioural changes in dogs treated with corticosteroids. Physiol Behav 2015; 151: 609–16. doi: 10.1016/j. physbeh.2015.08.041 37. Momayez Sanat Z, Mohajeri-Tehrani MR. Psychotic disorder as the first manifestation of addison disease: a case report. Int J Endocrinol Metab 2022; 14; 20(1): e121011. doi: 10.5812/ijem.121011 218 | Slov Vet Res 2023 | Vol 60 No 4 Agresivno vedenje psice po vstavitvi implantata deslorelina M. Zakošek Pipan, D. Pavlin Izvleček: V veterinarski praksi so dolgo delujoči analogi gonadotropin-sproščujočega hormona (GnRH) široko sprejeta alternativa kirurški kastraciji psov. Uporabljajo se tudi pri psicah bodisi za supresijo ali indukcijo estrusa, pri čemer gre za neoznačeno uporabo zdravila. Pri uporabi dolgo delujočih analogov GnRH so pri psicah opazili vedenjske spremembe, kot so moško obnašanje, povečan apetit, rast mlečnih žlez, laktacija, navidezna brejost in urinska inkontinenca. Pri pasjih samcih pa se lahko v začetnem obdobju, ko implantat spodbudi izločanje testosterona, pojavlja agresivnost do drugih psov ali redko drugih živali. Na naši kliniki smo obravnavali nesterilizirano, tri leta staro psico pasme koker španjel z diagnosticirano Addisonovo boleznijo. Lastniki so želeli nasvet glede možnosti kontracepcije, saj je pri psici v preteklih ciklusih prihajalo do navidezne brejosti in posledičnega mastitisa, ki je zahteval antibiotično zdravljenje. Lastniki so bili zadržani do kirurške sterilizaci- je, zato so se odločili za vstavitev deslorelinskega implantata. Približno mesec dni kasneje so pri psici opazili začetek agresivnega vedenja, ki je vključevalo stalno lajanje, izjemno razdražljivost in agresijo do drugih psov ter do družinskih članov. Neželeno vedenje se je stopnjevalo do te mere, da lastniki niso mogli več obvladovati svoje psice. Po odstranitvi implantata je opažena agresija umirila, in psica se je vrnila v normalno stanje. Čeprav je agresivno vedenje do drugih psov in včasih tudi do lastnikov opisano po kirurški kastraciji ali vstavitvi deslo- relinskega implantata pri psih, je ta prispevek prvi, ki opisuje izjemno agresivno vedenje do psov in lastnikov pri psici po vstavitvi 4,7 mg deslorelinskega implantata. Ključne besede: psica; agresija; vedenje; deslorelinski implantat; dolgo delujoči GnRH